NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
This Quarter Return
+3.32%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$4.46B
AUM Growth
+$4.46B
(+18%)
Cap. Flow
+$927M
Cap. Flow
% of AUM
20.81%
Top 10 Holdings %
Top 10 Hldgs %
62.58%
Holding
61
New
4
Increased
2
Reduced
4
Closed
3
Top Buys
| 1 |
Coursera
COUR
|
$952M |
| 2 |
MILE
Metromile, Inc. Common Stock
MILE
|
$96.6M |
| 3 |
Savara
SVRA
|
$50.2M |
| 4 |
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
|
$17.7M |
| 5 |
VistaGen Therapeutics
VTGN
|
$14.8M |
Top Sells
| 1 |
Palo Alto Networks
PANW
|
$95.5M |
| 2 |
Sprout Social
SPT
|
$89.2M |
| 3 |
DZSI
DZS Inc. Common Stock
DZSI
|
$14.3M |
| 4 |
Senseonics Holdings
SENS
|
$9.97M |
| 5 |
AFMD
Affimed
AFMD
|
$5.7M |
Sector Composition
| 1 | Healthcare | 52.55% |
| 2 | Consumer Staples | 21.37% |
| 3 | Industrials | 10.31% |
| 4 | Technology | 6.37% |
| 5 | Financials | 3.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRVN
51
DELISTED
Trevena, Inc.
TRVN
| $6.82M | 0.15% |
3,811,691
| – | – |
|
52
Liquidia Corp
LQDA
$2.52B
| $6.69M | 0.15% |
2,486,062
| – | – |
|
|
LUMO
53
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $6.16M | 0.14% |
526,663
| – | – |
|
|
PHXM
54
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
| $4.4M | 0.1% |
625,000
| – | – |
|
55
Tempest Therapeutics
TPST
$46.6M
| $2.12M | 0.05% |
1,766,779
| – | – |
|
|
AKTX
56
Akari Therapeutics
AKTX
$21.4M
| $1.19M | 0.03% |
452,167
| – | – |
|
|
DZSI
57
DELISTED
DZS Inc. Common Stock
DZSI
| $598K | 0.01% |
38,470
-917,785
| -96% | -$14.3M |
|
|
VIRX
58
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $343K | 0.01% |
37,093
-92,734
| -71% | – |
|
59
Palantir
PLTR
$367B
| – | – |
-59,980
| Closed | -$1.41M |
|
|
60
Palo Alto Networks
PANW
$128B
| – | – |
-268,684
| Closed | -$95.5M |
|
|
61
Senseonics Holdings
SENS
$368M
| – | – |
-11,464,235
| Closed | -$9.97M |
|